Select Med+
Cell & Gene+
Revolutionizing affordability and access to cell & gene therapies
Cell & gene therapies are at the forefront of medical advancement
Cell & gene therapies stand apart from traditional drug treatments due to their complex administration methods and high costs (reaching up to $3.5 million per therapy). These therapies present special challenges that must be resolved to make them readily accessible and affordable for patients who need them. The time to act is now.
$3.5
million
On average per therapy
40% cost
increase
Over the next three years
There are over 3,000 therapies in development*, and cell & gene costs are projected to increase by 20% - 30% annually through 2030.**
Synergie’s Cell & Gene+ was created to solve these complex challenges.
*American Society of Gene & Cell Therapy Website
**MagellanRx Management 2023 Trend Report
Cell & Gene+ Product Portfolio
Synergie has developed a market-leading integrated solutions portfolio for cell & gene therapies that includes the following products:
Gene+ Risk
Protection
Alleviates the volatility and financial burden for plan sponsors associated with multimillion dollar upfront payments for gene therapies, at the most competitive rates and best protection.
Outcomes+ Patient Navigation
Assists patients in identifying and accessing top-quality treatment centers across the United States to ensure access to these therapies at an affordable price.
Gene+
Outcomes
Value-based contracts that require the pharmaceutical manufacturers of gene therapies to provide value if the drug does not achieve defined clinical outcomes over a defined time-period.
Like with rebates, Synergie maintains a preferred drug list for gene therapies tied to its value based contracts. Click here to download our Outcomes+ Medical Drug List* and view the Cell & Gene therapy section.
The Synergie Difference
Synergie’s solutions are anchored by the largest data and risk pools in the United States. Synergie is a fully transparent and pass-through organization, meaning its sole focus is on making recommendations that serve the best interest of its participating health plans and passing through 100% of the value. In addition, we have partnered with top domain experts to ensure our solutions are best-in-class. Synergie is considered a leader in cell & gene management with our unique model.
Let’s Connect
Synergie Contact Form
For media inquiries please send to contact@synergiecollective.com